These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
445 related articles for article (PubMed ID: 27601434)
1. Relationship of grey and white matter abnormalities with distance from the surface of the brain in multiple sclerosis. Pardini M; Sudre CH; Prados F; Yaldizli Ö; Sethi V; Muhlert N; Samson RS; van de Pavert SH; Cardoso MJ; Ourselin S; Gandini Wheeler-Kingshott CA; Miller DH; Chard DT J Neurol Neurosurg Psychiatry; 2016 Nov; 87(11):1212-1217. PubMed ID: 27601434 [TBL] [Abstract][Full Text] [Related]
2. Cortical and Subcortical Morphometric and Iron Changes in Relapsing-Remitting Multiple Sclerosis and Their Association with White Matter T2 Lesion Load : A 3-Tesla Magnetic Resonance Imaging Study. Al-Radaideh A; Athamneh I; Alabadi H; Hbahbih M Clin Neuroradiol; 2019 Mar; 29(1):51-64. PubMed ID: 29299614 [TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal Fluid-In Gradient of Cortical and Deep Gray Matter Damage in Multiple Sclerosis. Rubin M; Pagani E; Preziosa P; Meani A; Storelli L; Margoni M; Filippi M; Rocca MA Neurol Neuroimmunol Neuroinflamm; 2024 Jul; 11(4):e200271. PubMed ID: 38896808 [TBL] [Abstract][Full Text] [Related]
4. DT MRI microstructural cortical lesion damage does not explain cognitive impairment in MS. Preziosa P; Pagani E; Morelli ME; Copetti M; Martinelli V; Pirro F; Falini A; Comi G; Filippi M; Rocca MA Mult Scler; 2017 Dec; 23(14):1918-1928. PubMed ID: 28098510 [TBL] [Abstract][Full Text] [Related]
5. Cortical Perfusion Alteration in Normal-Appearing Gray Matter Is Most Sensitive to Disease Progression in Relapsing-Remitting Multiple Sclerosis. Hojjat SP; Kincal M; Vitorino R; Cantrell CG; Feinstein A; Zhang L; Lee L; O'Connor P; Carroll TJ; Aviv RI AJNR Am J Neuroradiol; 2016 Aug; 37(8):1454-61. PubMed ID: 27012299 [TBL] [Abstract][Full Text] [Related]
6. Multiparameter MRI quantification of microstructural tissue alterations in multiple sclerosis. Lommers E; Simon J; Reuter G; Delrue G; Dive D; Degueldre C; Balteau E; Phillips C; Maquet P Neuroimage Clin; 2019; 23():101879. PubMed ID: 31176293 [TBL] [Abstract][Full Text] [Related]
8. Magnetization transfer ratio measures in normal-appearing white matter show periventricular gradient abnormalities in multiple sclerosis. Liu Z; Pardini M; Yaldizli Ö; Sethi V; Muhlert N; Wheeler-Kingshott CA; Samson RS; Miller DH; Chard DT Brain; 2015 May; 138(Pt 5):1239-46. PubMed ID: 25823475 [TBL] [Abstract][Full Text] [Related]
9. Higher EBV response is associated with more severe gray matter and lesion pathology in relapsing multiple sclerosis patients: A case-controlled magnetization transfer ratio study. Jakimovski D; Ramanathan M; Weinstock-Guttman B; Bergsland N; Ramasamay DP; Carl E; Dwyer MG; Zivadinov R Mult Scler; 2020 Mar; 26(3):322-332. PubMed ID: 30755085 [TBL] [Abstract][Full Text] [Related]
11. Spatial Correlation of Pathology and Perfusion Changes within the Cortex and White Matter in Multiple Sclerosis. Mulholland AD; Vitorino R; Hojjat SP; Ma AY; Zhang L; Lee L; Carroll TJ; Cantrell CG; Figley CR; Aviv RI AJNR Am J Neuroradiol; 2018 Jan; 39(1):91-96. PubMed ID: 29097413 [TBL] [Abstract][Full Text] [Related]
12. Increasing normal-appearing grey and white matter magnetisation transfer ratio abnormality in early relapsing-remitting multiple sclerosis. Davies GR; Altmann DR; Hadjiprocopis A; Rashid W; Chard DT; Griffin CM; Tofts PS; Barker GJ; Kapoor R; Thompson AJ; Miller DH J Neurol; 2005 Sep; 252(9):1037-44. PubMed ID: 15834645 [TBL] [Abstract][Full Text] [Related]
13. Imaging patterns of gray and white matter abnormalities associated with PASAT and SDMT performance in relapsing-remitting multiple sclerosis. Riccitelli GC; Pagani E; Rodegher M; Colombo B; Preziosa P; Falini A; Comi G; Filippi M; Rocca MA Mult Scler; 2019 Feb; 25(2):204-216. PubMed ID: 29173009 [TBL] [Abstract][Full Text] [Related]
14. Two-year regional grey and white matter volume changes with natalizumab and fingolimod. Preziosa P; Rocca MA; Pagani E; Storelli L; Rodegher M; Moiola L; Filippi M J Neurol Neurosurg Psychiatry; 2020 May; 91(5):493-502. PubMed ID: 32111638 [TBL] [Abstract][Full Text] [Related]
15. The relationship between cortical lesions and periventricular NAWM abnormalities suggests a shared mechanism of injury in primary-progressive MS. Pardini M; Petracca M; Harel A; Fleysher L; Oesingmann N; Bommarito G; Fabian M; Chard D; Lublin F; Inglese M Neuroimage Clin; 2017; 16():111-115. PubMed ID: 28794971 [TBL] [Abstract][Full Text] [Related]
16. A longitudinal study of cortical grey matter lesion subtypes in relapse-onset multiple sclerosis. Sethi V; Yousry T; Muhlert N; Tozer DJ; Altmann D; Ron M; Wheeler-Kingshott C; Miller DH; Chard DT J Neurol Neurosurg Psychiatry; 2016 Jul; 87(7):750-3. PubMed ID: 26272028 [TBL] [Abstract][Full Text] [Related]
17. Characterization of white matter lesions in multiple sclerosis using proton density and T1-relaxation measures. Buch S; Subramanian K; Chen T; Chen Y; Larvie M; Bernitsas E; Haacke EM Magn Reson Imaging; 2024 Feb; 106():110-118. PubMed ID: 38145698 [TBL] [Abstract][Full Text] [Related]
18. NODDI, diffusion tensor microstructural abnormalities and atrophy of brain white matter and gray matter contribute to cognitive impairment in multiple sclerosis. Preziosa P; Pagani E; Meani A; Marchesi O; Conti L; Falini A; Rocca MA; Filippi M J Neurol; 2023 Feb; 270(2):810-823. PubMed ID: 36201016 [TBL] [Abstract][Full Text] [Related]
19. Multi-parametric quantitative MRI of normal appearing white matter in multiple sclerosis, and the effect of disease activity on T2. Reitz SC; Hof SM; Fleischer V; Brodski A; Gröger A; Gracien RM; Droby A; Steinmetz H; Ziemann U; Zipp F; Deichmann R; Klein JC Brain Imaging Behav; 2017 Jun; 11(3):744-753. PubMed ID: 27138529 [TBL] [Abstract][Full Text] [Related]
20. Unraveling the heterogeneous pathological substrates of relapse-onset multiple sclerosis: a multiparametric voxel-wise 3 T MRI study. Margoni M; Pagani E; Preziosa P; Gueye M; Azzimonti M; Rocca MA; Filippi M J Neurol; 2023 Aug; 270(8):3839-3850. PubMed ID: 37093395 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]